Entry Point Capital, LLC Harmony Biosciences Holdings, Inc. Transaction History
Entry Point Capital, LLC
- $188 Million
- Q2 2025
A detailed history of Entry Point Capital, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 12,296 shares of HRMY stock, worth $436,139. This represents 0.21% of its overall portfolio holdings.
Number of Shares
12,296
Previous 12,770
3.71%
Holding current value
$436,139
Previous $423,000
8.27%
% of portfolio
0.21%
Previous 0.21%
Shares
6 transactions
Others Institutions Holding HRMY
# of Institutions
288Shares Held
46.3MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$235 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$181 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$56 Million0.0% of portfolio
-
Lsv Asset Management Chicago, IL1.49MShares$52.8 Million0.11% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.1B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...